EMUC24: Day 3 highlights
Below you can review some of the key topics covered at the EMUC25 Congress on Day 3. We share webcasts, session reports, best abstracts and photo impressions.
Report: The Big PCa game-changers for 2025!
In an auditorium packed to capacity, the ‘Game-changing’ session today offered a concise wrap-up of an exceptional year in oncology research, particularly for prostate cancer patients. Read this report summarising the presentations on PSMAddition, AMPLITUDE, CAPItello-281, and EMBARK results.
Webcasts of the day
CREST
T. Powles, London (GB)
CC Case: Systemic treatment for RCC – What to do with the primary tumour? Take it out or let the drug do the work?
U. Vogl, Bellinzona (CH), G. Pignot, Marseille (FR), and Y. Ürün, Ankara (TR)
Report: Hereditary GU cancers session examines BRCA and PRS
Is prostate cancer (PCa) risk elevated in individuals with BRCA mutations? What is the potential of polygenic risk score (PRS) in PCa screening? Experts explored these topics during “Plenary Session 8: Hereditary genito-urinary cancers” held on day 3 of EMUC25.
Photos from the congress floor in Prague
Check out our photo albums of Day 3 of EMUC25 and Abstract Award winners on Facebook. Share your photos and stories on Instagram, LinkedIn, and X as well.
Best EMUC25 Abstracts
O04: Real world evidence of adjuvant pembrolizumab in renal cell carcinoma (RCC) from a Spanish registry: The ARENAL trial from the GUARD consortium.
M.I. Galante Romo, Madrid (ES)
O01: ONE SHOT – single shot radiotherapy for localized prostate cancer: primary endpoint results of a single arm, multicenter, prospective phase I/II trial
T. Zilli, Bellinzona (CH)
O03: Secondary outcomes by prior definitive treatment (tx) in patients (pts) with high-risk biochemically recurrent prostate cancer (hrBCR) treated with enzalutamide plus leuprolide (enza combo): EMBARK post hoc analysis
A.S. Rannikko, Espoo (FI)
EMUC25 Resource Centre
Missed a session? All webcasts, videos, posters and full-text abstracts EMUC25 are available via the Resource Centre. For participants, viewing EMUC25 webcasts will also earn you CME accreditation. Webcasts are accredited up until Monday, 17 November 2025 (13:00 CET).